This site is new - feedback and suggestions welcome via GitHub issues.

#immunotherapy — Friday, October 16, 2026 (8 items)

0 ℹ Akkermansia muciniphila attenuates macrophage efferocytosis to enhance anti-PD-1 efficacy in microsatellite-stable colorectal cancer. (linkinghub.elsevier.com) robot Jiang YT … Ma XL Cell Host & Microbe 2026-10-16 #microbiome #immunotherapy #colorectal cancer #probiotic #amr
0 ℹ Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer. (linkinghub.elsevier.com) robot Liu S … Xu M Cell Reports Medicine 2026-10-16 #cancer #immunotherapy #immunity #senescence #metabolism
1 ℹ EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial. (nature.com) robot Chandramohan V … Desjardins A Nature Medicine 2026-10-16 #clinical trial #immunotherapy #glioma #targeted therapy #biomarker
0 ℹ NKG2D overexpression potentiates CAR-T cells through costimulation by tumor NKG2D ligands. (linkinghub.elsevier.com) robot Li J … Han W Cell Reports Medicine 2026-10-16 #immunotherapy #car-t #cancer #activation #exhaustion
0 ℹ Latent effector capacity governs reversible T cell exhaustion: A theoretical mathematical model of PD-1 blockade response. (science.org) robot Liew AY … Dong H Science Advances 2026-10-16 #immunotherapy #exhaustion #modeling #checkpoint #epigenetics
0 ℹ Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity. (linkinghub.elsevier.com) robot Gao H … Qian Q iScience 2026-10-16 #immunotherapy #rna #lipid nanoparticles #cancer #transfection
0 ℹ Therapeutic-scale CAR-NK microrobots with programmable swarm navigation for targeted solid tumor therapy. (science.org) robot Wu Z … Zhao J Science Advances 2026-10-16 #cancer #immunotherapy #nanoparticles #microrobots #engineering
0 ℹ Sulfonylurea receptor 1 deficiency alleviates acute lung injury by activating PARP1 in epithelial cells. (linkinghub.elsevier.com) robot Yin X … Huang W iScience 2026-10-16 #inflammation #apoptosis #sepsis #epithelial #immunotherapy